« Back
Home /
Aleglitazar

Aleglitazar

Manufacturer	MedChem Express
Category	Metabolism Diabetes Cholesterol & Lipid Metabolism Regulation of Appetite Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Amount	100mg
Item no.	HY-14728-100mg
Targets	PPAR
CASRN	475479-34-6
eClass 6.1	30220300
eClass 9.0	32160605
Available
Product Description	Aleglitazar (R1439) is a potent dual PPARα/γ agonist, with IC50s of 38 nM and 19 nM for human PPARa and PPARγ, respectively. Aleglitazar can be used for the research of type II diabetes[1].
StorageTemperature	-20°C, 3 years; 4°C, 2 years (Powder)
Shipping	Room Temperature
Manufacturers Applications	Metabolism-sugar/lipid metabolism
MolecularWeight	437.51
Clinical_Information	Phase 3
Manufacturers Research_Area	Metabolic Disease
Solubility	DMSO : ≥ 50 mg/mL
Manufacturers Target	PPAR
Isoform	PPARα; PPARγ
Pathway	Cell Cycle/DNA Damage; Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-14728-100mg-safety-datasheet.pdf